Compare Gap Inc (GAP) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gap Inc vs IDEXX Laboratories, Inc. — how do they compare? Gap Inc trades at $20.65 (market cap $7.30B), while IDEXX Laboratories, Inc. trades at $572.1 (market cap $43.94B). The key difference: IDEXX Laboratories, Inc. is far larger — about 6× Gap Inc's market cap, and Gap Inc pays a 3.45% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| GAP | IDXX | |
|---|---|---|
Market Cap | $7.30B | $43.94B |
Sector | Consumer Cyclical | Health |
52-Week High | $29.13 | $766.68 |
52-Week Low | $18.35 | $514.61 |
Enterprise Value | $10.38B | $44.84B |
Dividend Yield | 3.45% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gap Inc. (GAP) trades at $20.65, up 2.58% today, with a bullish technical signal supported by oscillators and key resistance at $21. The stock shows strong fundamentals with a P/E of 8.05, net income margin of 6.25%, and consistent earnings beats in recent quarters. Revenue grew to $15.09B in 2025, and operating cash flow remains robust at $1.49B. Recent news highlights digital transformation efforts and a potential turnaround in the Athleta segment.
The outlook is positive with a consensus price target of $27.00, implying 30.7% upside, though risks include ongoing legal investigations and competitive pressures. Analyst sentiment is mixed with 39.58% buy ratings, but improving profitability and undervalued metrics support a constructive view for long-term investors.
IDXX stock trades at $540.68, down 4.15% in the last session, with technical indicators showing a bearish bias. Fundamentally, the company demonstrates strong profitability with a 24.63% net margin and consistent earnings beats in recent quarters. Revenue growth continues, reaching $4.3B in 2025. Analyst sentiment remains predominantly positive with a 59% buy rating, though technical signals conflict with this fundamental strength.
The outlook balances robust fundamentals against technical weakness. Investment opportunity lies in sustained high profitability and market leadership in veterinary diagnostics, but risks include elevated valuation multiples (P/E 40.99) and bearish technical momentum that may pressure the stock near-term despite positive analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gap Inc
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
